10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,296,000 | -57.6% | 501,952 | -32.6% | 0.02% | -55.3% |
| Q2 2022 | $33,678,000 | -35.2% | 744,274 | +9.0% | 0.05% | -21.7% |
| Q1 2022 | $51,946,000 | -51.3% | 682,863 | -4.6% | 0.06% | -53.8% |
| Q4 2021 | $106,593,000 | -0.1% | 715,581 | -2.4% | 0.13% | -12.2% |
| Q3 2021 | $106,748,000 | -24.8% | 733,247 | +1.2% | 0.15% | -22.9% |
| Q2 2021 | $141,905,000 | +59.3% | 724,669 | +47.2% | 0.19% | +45.5% |
| Q1 2021 | $89,084,000 | +16.2% | 492,181 | -9.1% | 0.13% | +116.4% |
| Q4 2020 | $76,686,000 | +109.5% | 541,570 | +84.4% | 0.06% | -9.0% |
| Q3 2020 | $36,608,000 | +54.0% | 293,615 | +10.3% | 0.07% | +39.6% |
| Q2 2020 | $23,774,000 | +52.5% | 266,203 | +6.4% | 0.05% | +26.3% |
| Q1 2020 | $15,588,000 | +132.9% | 250,081 | +184.9% | 0.04% | +192.3% |
| Q4 2019 | $6,694,000 | +384.0% | 87,773 | +219.9% | 0.01% | +333.3% |
| Q3 2019 | $1,383,000 | – | 27,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |